Mount Sinai Health System Hospital Campuses: Mount Sinai Beth IsraelMount Sinai Beth Israel BrooklynThe Mount Sinai Hospital
Mount Sinai QueensMount Sinai RooseveltMount Sinai St. Luke'sNew York Eye and Ear Infirmary of Mount Sinai
Mun K. Hong, MD
Director, Interventional Cardiology; Director, Cardiac Catheterization Laboratory, Mount Sinai St. Luke's Roosevelt
Photo of Mun K. Hong, MD
Affiliated with:
Mount Sinai St. Luke’s Roosevelt
Center, Institute, ProgramContinuum Cardiovascular Centers of New York
University Medical Practice Associates
Medical SpecialtyCardiology
Interventional Cardiology
Clinical Interests
Cardiac Catheterization
Carotid Artery Disease
Heart Disease
High Blood Pressure
High Cholesterol
Peripheral Vascular Disease
Stress Tests
Coronary Artery Disease
Peripheral Interventions Structural Heart Disease
Acute Coronary Syndrome
Insurance See Insurance Providers
Board CertificationsAmerican Board of Internal Medicine, 1989
American Board of Internal Medicine, Cardiovascular Disease, 1993, Recertified, 2003
American Board of Internal Medicine, Interventional Cardiology, 1999; Recertified, 2009
Medical SchoolJohns Hopkins University School of Medicine, Baltimore, MD, 1986
Residency TrainingInternal Medicine, Johns Hopkins Hospital, Baltimore, MD, 1987‑1989
FellowshipInterventional Cardiology, Washington Hospital Center, Washington, DC, 1991‑1993
Cardiology, Georgetown University Hospital, 1989‑1991
Academic AppointmentIcahn School of Medicine at Mount Sinai
Clinical StudiesAcute coronary syndromes; antiplatelet therapy
Research / AdvancesImportance of distal protection during saphenous vein graft intervention and the necessity for local drug-delivery for prevention of restenosis.
From the doctorDr. Hong completed combined clinical and research fellowship at Washington Hospital Center under the mentorship of Dr. Kenneth Kent and Dr. Martin Leon. His seminal clinical research in saphenous vein graft intervention illustrated the importance of distal protection during this high-risk procedure and whose preclinical research in local drug delivery demonstrated the need for drug-eluting stents to prevent restenosis.

Following his fellowship in 1993, he joined the Washington Cardiology Center/Cardiovascular Research Foundation as the director of experimental physiology and pharmacology and conducted both preclinical and clinical research as well as complex interventions till 2000. In 2000, he joined Weill Cornell Medical College faculty as Associate Professor of Medicine and Director of Cardiovascular Intervention and Research. Since 2006, he has been the director of cardiac catheterization laboratory and interventional cardiology at Mount Sinai St. Luke's Roosevelt, where he has been performing complex coronary and peripheral interventions. He has published over 100 peer-reviewed publications in interventional cardiology. He is also Co-Editor of “Acute Coronary Syndrome: Multidisciplinary and Pathway-Based Approach” published by Springer. He has been the co-director of symposia on multi-disciplinary approach to acute coronary syndrome management.

View Dr. Hongs's presentation named "Interventional Cardiology in 2012 and Beyond."
Address425 West 59th Street, Suite 9C
New York NY 10019
Telephone: (212) 492-5550

374 West 125th Street
New York NY 10027
Telephone: (212) 280-3101

38-30 Parsons Boulevard, Suite 1E
Flushing NY 11354
Telephone: (718) 886-5544
*All Board Certifications and Subspecialty Certifications are granted by The American Board of Medical Specialties, unless otherwise noted.
Privacy Policy | Site Map
Copyright ©  Icahn School of Medicine at Mount Sinai | Mount Sinai Health System